The global lateral flow assay market is projected to grow from USD 11.04 billion in 2026 to USD 16.37 billion by 2031, ...
AUSTIN, Texas and TOKYO, Sept. 9, 2025 /PRNewswire/ -- "The Lateral Flow Assays Market Size was US$ 7.51 billion in 2024, with a rise of US$ 7.50 billion in 2024, and is expected to reach US$ 15.68 ...
Dublin, June 25, 2025 (GLOBE NEWSWIRE) -- The "U.S. And Europe Lateral Flow Assay Market Size, Share & Trends Analysis Report Product (Kits & Reagents, Lateral Flow Readers), By Application, By ...
Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...
Lateral flow assays, also called immunochromatographic assays, identify or measure biomolecules in intricate samples like blood, saliva, urine, or other fluids to diagnose numerous medical conditions.
Intelligent Bio Solutions expects a sixth U.S. patent for its innovative non-invasive drug testing technology, enhancing market entry plans. Intelligent Bio Solutions Inc. (INBS), a medical technology ...
Lateral flow immunoassays (LFIAs) represent a class of paper-based diagnostic devices designed for rapid, on-site detection of specific biomarkers in complex samples. At their core, these assays rely ...
The global lateral flow assay market is projected to grow from USD 11.04 billion in 2026 to USD 16.37 billion by 2031, registering a CAGR of 8.2% during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results